ATE479653T1 - Carboxyalkoxy-substituierte acyl-carboxyphenyl- harnstoffderivate, verfahren zu ihre herstellung und ihre verwendung als arzneimittel - Google Patents

Carboxyalkoxy-substituierte acyl-carboxyphenyl- harnstoffderivate, verfahren zu ihre herstellung und ihre verwendung als arzneimittel

Info

Publication number
ATE479653T1
ATE479653T1 AT03757879T AT03757879T ATE479653T1 AT E479653 T1 ATE479653 T1 AT E479653T1 AT 03757879 T AT03757879 T AT 03757879T AT 03757879 T AT03757879 T AT 03757879T AT E479653 T1 ATE479653 T1 AT E479653T1
Authority
AT
Austria
Prior art keywords
urea derivatives
carboxyalkoxy
alkyl
production
substituted acyl
Prior art date
Application number
AT03757879T
Other languages
English (en)
Inventor
Elisabeth Defossa
Dieter Kadereit
Thomas Klabunde
Hans-Joerg Burger
Andreas Herling
Karl-Ulrich Wendt
Reodern Erich Von
Karl Schoenafinger
Alfons Enhsen
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE479653T1 publication Critical patent/ATE479653T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48Y being a hydrogen or a carbon atom
    • C07C275/54Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03757879T 2002-10-04 2003-09-22 Carboxyalkoxy-substituierte acyl-carboxyphenyl- harnstoffderivate, verfahren zu ihre herstellung und ihre verwendung als arzneimittel ATE479653T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10246434A DE10246434B4 (de) 2002-10-04 2002-10-04 Carboxyalkoxy-substituierte Acyl-carboxyphenyl-harnstoffderivate und ihre Verwendung als Arzneimittel
PCT/EP2003/010501 WO2004033416A2 (de) 2002-10-04 2003-09-22 Carboxyalkoxy-substituierte acyl-carboxyphenyl-harnstoffderivate, verfahren zu ihre herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ATE479653T1 true ATE479653T1 (de) 2010-09-15

Family

ID=32010248

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03757879T ATE479653T1 (de) 2002-10-04 2003-09-22 Carboxyalkoxy-substituierte acyl-carboxyphenyl- harnstoffderivate, verfahren zu ihre herstellung und ihre verwendung als arzneimittel

Country Status (9)

Country Link
EP (1) EP1556339B1 (de)
JP (1) JP4355290B2 (de)
AT (1) ATE479653T1 (de)
AU (1) AU2003273913A1 (de)
BR (1) BR0314861A (de)
CA (1) CA2500763A1 (de)
DE (2) DE10246434B4 (de)
MX (1) MXPA05003320A (de)
WO (1) WO2004033416A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10306502B4 (de) * 2003-02-17 2005-03-17 Aventis Pharma Deutschland Gmbh Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2612669A4 (de) 2010-08-31 2014-05-14 Snu R&Db Foundation Verwendung der fötalen neuprogrammierung eines ppar-agonisten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE860511L (en) * 1985-03-01 1986-09-01 Alfa Farmaceutici Spa "Benzoyl urea derivatives having anti-tumor activity"
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
NZ523034A (en) * 2000-06-09 2004-07-30 Aventis Pharma Gmbh Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament

Also Published As

Publication number Publication date
BR0314861A (pt) 2005-08-02
JP4355290B2 (ja) 2009-10-28
DE10246434B4 (de) 2005-08-04
MXPA05003320A (es) 2005-07-05
DE50313047D1 (de) 2010-10-14
WO2004033416A2 (de) 2004-04-22
CA2500763A1 (en) 2004-04-22
JP2006502206A (ja) 2006-01-19
EP1556339B1 (de) 2010-09-01
EP1556339A2 (de) 2005-07-27
AU2003273913A1 (en) 2004-05-04
WO2004033416A3 (de) 2004-05-13
DE10246434A1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
ATE427302T1 (de) Arylsulphonamidderivat und deren verwendung als b1-bradykinin rezeptor antagonisten
ATE491691T1 (de) Disubstituierte pyrazolylcarboxanilide
RU2009118281A (ru) Гетероциклические ингибиторы мек и способы их применения
MA30878B1 (fr) 4-[4-({[4-chloro-3-(trifluorométhyl) phényl]carbamoyl}amino)-3-fluorophénoxy]-n-méthylpyridine-2-carboxamide monohydraté
EA200300621A1 (ru) Биарильные производные никотинамида, полезные в качестве ингибиторов изоферментов pde4
BG107960A (bg) Етерни производни използвани като инхибитори на pde4 изозими
EA200500474A1 (ru) Производные хинолилпропилпиперидина и их применение в качестве антимикробных средств
ECSP055644A (es) Derivados de la quinolil-propil-piperidina y su utilización
WO2007041494A3 (en) Cholesteryl ester transfer protein inhibitors
ITRM20020016A0 (it) Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
RU2013127155A (ru) Новые замещенные бициклические ароматические соединения в качестве ингибиторов s-нитрозоглутатион-редуктазы
ATE479653T1 (de) Carboxyalkoxy-substituierte acyl-carboxyphenyl- harnstoffderivate, verfahren zu ihre herstellung und ihre verwendung als arzneimittel
DE602006008320D1 (de) Pyrrolopyridin-derivate und deren verwendung als ppar-rezeptormodulatoren
DE69621877D1 (de) 4-Indolylpiperazinyl-Derivate
CY1112878T1 (el) Νεο αλας βενζοϋλογονανιδινης
BRPI0510278A (pt) método para produzir compostos, produto, e, composto
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
ATE343566T1 (de) Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren
JP2010527364A5 (de)
FR2839974A1 (fr) Derives de phenyl-furane ou de phenyl-thiophene,leur preparation et leur application a titre de medicament
UA86077C2 (en) Cetp inhibitors
WO2004026930A3 (en) The method for reducing inflammation using sti-571 or its salt
GT200000024A (es) Compuestos de 1, 2, 3, 4 - tetrahidro - 1 - naftalenamina utiles en terapia.
CY1105789T1 (el) Νεα μεθοδος για τη συνθεση πepιντοπριλ και των φαρμακευτικως αποδεκτων αλατων αυτου
DE602004002464D1 (de) IMIDAZOi4,5-BöCHINOLINDERIVATE UND IHRE VERWENDUNG ALS INHIBITOREN DER INDUZIERBAREN NO-SYNTHASE

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee